Skip to main content

Wuhan Healthcare Biotech

wuhan_healthcare_biotech

Wuhan HealthCare Biotechnology Co., Ltd. (HealthCare) is an original manufacturer of ready to use cutting-edge molecular testing solutions and instruments for oncology bio-clinical research and diagnosis. HealthCare products are answers to challenges laboratories face on a day-to-day basis by offering a wide range of reagents. Their Fluorescence In-Situ Hybridization (FISH) probe kits for solid tumors and blood cancers compete with global brands due to their quality and performance, thus helping health professionals make the most accurate diagnosis, determine the best treatment and give the most appropriate follow-up to cancer patients. They are the best response to overly long manipulation processes and testing operations; to too high costs incurred by laboratories, hospitals, diagnostics centres & medical research institutes.

Our product lines consist of:

  • Fluorescence In-Situ Hybridization (FISH) probe ready to use kits & Customized FISH probes (FastProbe®) for oncohematology testing (tissue sample and blood cell sample).
  • Real-Time PCR-based assays (qPCR) for Human genotyping.
  • FISH pretreatment reagent kits.
  • Instruments - Fluorescence In Situ Hybridization (FISH) slides automatic pretreatment system.

www.healthcare-biotech.com/

The prices are on request! Contact Us by e-mail info@sobekbio.com

DIMA Biotech

DIMA_Biotech

DIMA Biotechnology Ltd. is a biotech company focusing on preclinical R&D products and services for druggable targets. They plan to complete the preparation of lead antibody molecules for all druggable targets in the next 3-5 years. DIMA Biotech provides multiple pre-prepared lead antibody molecules for each target to help pharmaceutical companies skip the tedious steps of monoclonal antibody platform establishment and lead molecule screening. Therefore,  companies can  have more time to focus on the biological mechanism and developability study of drug targets, thus accelerating the process of new drug R&D.

Over the years, DIMA Biotech has been deeply engaged in developing and optimizing the underlying technology platforms for preclinical research. Currently, they have established two independently developed core technology platforms:

Single/multiple transmembrane protein eukaryotic expression, preparation and purification platforms, apply mammalian cell expression systems, provide ECD or full-length membrane protein products closest to native conformation and functional validation. In addition, DIMA Biotech has developed five major functional full-length transmembrane protein preparation systems, including Membrane Nanoparticle (MNP), Virus-Like Particle (VLP), Exosome (EXO), Detergent and Synthetic Nanodisc. Thousands of drug target protein products are in stock. 
DimAb® High-throughput single B-cell lead antibody molecule discovery platform. DIMA Biotech has completed the preparation and screening of lead antibody molecules against more than 200 drug targets by this platform in just two years. Moreover, they have formed strategic partnerships with several international pharmaceutical enterprises and licensed several drug target molecules. DIMA’s preclinical development strength is widely recognized by the industry. 


www.dimabio.com

The prices are on request! Contact Us by e-mail info@sobekbio.com

Reed Biotech

reed_biotech

Reed Biotech Ltd is a high-tech biological company,  focusing on the field of biological immune protein research. They firmly believe in the philosophy of cyclic symbiosis between human and nature, and integrate it into our business and products. Reed Biotech are committed to providing high-quality reagents and solutions for the global scientific research and medical industry, to promote the harmonious development of human and nature.

Reed Biotech® antibody line covers a variety of animal-derived second antibodies and polyclonal antibodies, Reed also provides customized services based on monoclonal antibodies. Their ELISA includes various types of immunoassay kits for human, mouse, rat and other species, covering a variety of detection indicators. Additionally Reed’s biochemical analysis comprises an assortment of enzyme-linked immunoassay (ELISA) reagents, enzyme labeling reagents, chromogenic substrates, etc., which can meet customers' needs for the detection of various biomolecules. Their recombinant protein line includes proteins from various species, such as human, mouse, and rat. And Reed’s immune-related reagents cover a variety of cytokines, cytokine receptors, signaling pathways, etc. Reed Biotech has strict quality control in their products, all out-of-warehouse items must pass the GMP standard and ISO: 9001 to ensure products’ stability.

These products play an important role in the field of biomedical research. Reed Biotech focuses on the quality and sustainability of the products, striving to reduce the impact on the environment, and actively participate in ecological conservation and sustainable development initiatives. In their R&D and production processes, Reed has adopted advanced technologies and methods to minimize the consumption and pollution of natural resources. They strictly control the products production process to ensure the compliance of pro-environment, and actively promote greening production. Reed is actively conducting research to find environmentally-friendly and sustainable alternatives for our customers.

www.reedbiotech.com

The prices are on request! Contact Us by e-mail info@sobekbio.com